{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:41:39Z","timestamp":1771231299687,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.gofs.2023.12.010","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:34:42Z","timestamp":1704515682000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peut-on surseoir au curage axillaire en cas de carcinome mammaire invasif avec envahissement ganglionnaire\u00a0?"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-156X","authenticated-orcid":false,"given":"Susie","family":"Brousse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9mentine","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-6610","authenticated-orcid":false,"given":"Martin","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Guillermet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-9725","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Moli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-0210","authenticated-orcid":false,"given":"Carole","family":"Mathelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0345","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","article-title":"I.\u00a0The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gofs.2023.12.010_bib0350","first-page":"1221","article-title":"Modified radical mastectomy","volume":"121","author":"Madden","year":"1965","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.gofs.2023.12.010_bib0355","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/SLA.0000000000005671","article-title":"Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis","volume":"277","author":"Che Bakri","year":"2023","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gofs.2023.12.010_bib0360","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2023.12.010_bib0365","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","article-title":"Improved axillary staging of breast cancer with sentinel lymphadenectomy","volume":"222","author":"Giuliano","year":"1995","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.gofs.2023.12.010_bib0370","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.gofs.2023.12.010_bib0375","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.breast.2007.08.006","article-title":"Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group","volume":"17","author":"Husted Madsen","year":"2008","journal-title":"Breast"},{"issue":"9069","key":"10.1016\/j.gofs.2023.12.010_bib0380","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0385","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32\u00a0randomised phase 3\u00a0trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"27","key":"10.1016\/j.gofs.2023.12.010_bib0390","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the Axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2023.12.010_bib0395","series-title":"Traitements locor\u00e9gionaux des cancers du sein infiltrants non m\u00e9tastatiques \u2013 th\u00e9saurus partie 1. Collection Recommandations et r\u00e9f\u00e9rentiels\/Recommandations de pratique clinique","author":"INCa","year":"2021"},{"key":"10.1016\/j.gofs.2023.12.010_bib0400","series-title":"Traitements locor\u00e9gionaux des cancers du sein infiltrants non m\u00e9tastatiques \u2013 th\u00e9saurus partie 2. Collection Recommandations et r\u00e9f\u00e9rentiels\/Recommandations de pratique clinique","author":"INCa","year":"2022"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0405","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2023.12.010_bib0410","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000517208","article-title":"Targeted axillary dissection after chemotherapy: feasibility study with clip and carbon dye tattoo \u2013 Neotarget Trial","volume":"17","author":"Pinto","year":"2022","journal-title":"Breast Care (Basel)"},{"issue":"14","key":"10.1016\/j.gofs.2023.12.010_bib0415","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.gofs.2023.12.010_bib0420","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.gofs.2023.12.010_bib0425","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.gofs.2023.12.010_bib0430","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10549-022-06588-2","article-title":"False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy","volume":"193","author":"de Boniface","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0435","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"5_Supplement","key":"10.1016\/j.gofs.2023.12.010_bib0440","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS22-OT1-09-01","article-title":"Axillary surgery de-escalation after neoadjuvant chemotherapy in breast cancer patients with initially involved node: the GANEA 3\u00a0trial","volume":"83","author":"Renaudeau","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.gofs.2023.12.010_bib0445","doi-asserted-by":"crossref","first-page":"6111907","DOI":"10.1155\/2022\/6111907","article-title":"Evaluation of axillary lymph node marking with Magseed(R) before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study","volume":"2022","author":"Martinez","year":"2022","journal-title":"Breast J"},{"issue":"6","key":"10.1016\/j.gofs.2023.12.010_bib0500","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ejso.2019.12.007","article-title":"Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy","volume":"46","author":"Balasubramanian","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2023.12.010_bib0515","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2214\/AJR.19.21378","article-title":"Feasibility of magnetic seeds for preoperative localization of axillary lymph nodes in breast cancer treatment","volume":"213","author":"Greenwood","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.gofs.2023.12.010_bib0525","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.suronc.2020.11.013","article-title":"Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer","volume":"36","author":"Mariscal Martinez","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.gofs.2023.12.010_bib0530","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clinimag.2018.07.008","article-title":"SAVI SCOUT(R) localization of breast lesions as a practical alternative to wires: Outcomes and suggestions for trouble-shooting","volume":"52","author":"Falcon","year":"2018","journal-title":"Clin Imaging"},{"issue":"7","key":"10.1016\/j.gofs.2023.12.010_bib0520","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.21873\/anticanres.14352","article-title":"Savi Scout(R) radar localisation of non-palpable breast lesions: systematic review and pooled analysis of 842\u00a0cases","volume":"40","author":"Kasem","year":"2020","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.gofs.2023.12.010_bib0455","doi-asserted-by":"crossref","first-page":"e1621","DOI":"10.1634\/theoncologist.2020-0494","article-title":"Would removal of all ultrasound abnormal metastatic lymph nodes without sentinel lymph node biopsy be accurate in patients with breast cancer with neoadjuvant chemotherapy?","volume":"25","author":"Lim","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.gofs.2023.12.010_bib0670","first-page":"1863","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"issue":"9","key":"10.1016\/j.gofs.2023.12.010_bib0450","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/a-1889-7883","article-title":"Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in Germany: initial data from the AXSANA study","volume":"82","author":"Hartmann","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"10.1016\/j.gofs.2023.12.010_bib0460","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","article-title":"Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0\u00a0after treatment","volume":"19","author":"Natsiopoulos","year":"2019","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0465","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000513037","article-title":"False negativity of targeted axillary dissection in breast cancer","volume":"16","author":"Kirkilesis","year":"2021","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.gofs.2023.12.010_bib0470","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12885-019-6095-1","article-title":"Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2023.12.010_bib0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.suronc.2019.05.019","article-title":"Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results","volume":"30","author":"Flores-Funes","year":"2019","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0480","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.1016\/j.clbc.2018.02.001","article-title":"Enhanced axillary evaluation using reflector-guided sentinel lymph node biopsy: a prospective feasibility study and comparison with conventional lymphatic mapping techniques","volume":"18","author":"Taback","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2023.12.010_bib0485","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4143\/crt.2017.210","article-title":"Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients","volume":"50","author":"Park","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0490","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/tbj.13736","article-title":"Targeted axillary dissection of carbon-tattooed metastatic lymph nodes in combination with post-neo-adjuvant sentinel lymph node biopsy using 1\u00a0% methylene blue in breast cancer patients","volume":"26","author":"Khallaf","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.gofs.2023.12.010_bib0495","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/11782234231176159","article-title":"Marking techniques for targeted axillary dissection among patients with node-positive breast cancer treated with neoadjuvant chemotherapy","volume":"17","author":"Gante","year":"2023","journal-title":"Breast Cancer (Auckl)"},{"issue":"9","key":"10.1016\/j.gofs.2023.12.010_bib0505","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gofs.2023.12.010_bib0510","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejso.2022.12.019","article-title":"Clinical utility of axillary nodal markers in breast cancer","volume":"49","author":"Barry","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2023.12.010_bib0535","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.crad.2020.08.014","article-title":"Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150\u00a0cases in a UK breast unit","volume":"75","author":"Lowes","year":"2020","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2023.12.010_bib0540","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10549-019-05355-0","article-title":"Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions","volume":"177","author":"McGugin","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0545","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs. no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.gofs.2023.12.010_bib0550","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023\u00a0AMAROS Trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0555","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3\u00a0trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2023.12.010_bib0560","doi-asserted-by":"crossref","first-page":"8404035","DOI":"10.1155\/2019\/8404035","article-title":"Can we identify or exclude extensive axillary nodal involvement in breast cancer patients preoperatively?","volume":"2019","author":"Leenders","year":"2019","journal-title":"J Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0565","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2023.12.010_bib0570","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2\u00a0study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.gofs.2023.12.010_bib0575","doi-asserted-by":"crossref","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.gofs.2023.12.010_bib0580","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12957-023-03174-8","article-title":"Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience","volume":"21","author":"Pislar","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"5_Supplement","key":"10.1016\/j.gofs.2023.12.010_bib0585","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS22-GS4-02","article-title":"Oncological outcomes following omission of axillary lymph node dissection in node positive patients downstaging to node negative with neoadjuvant chemotherapy: the OPBC-04\/EUBREAST-06\/OMA study","volume":"83","author":"Montagna","year":"2023","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.gofs.2023.12.010_bib0590","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA Study","volume":"13","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0595","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0600","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2023.12.010_bib0605","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0610","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1055\/a-1674-1114","article-title":"Correction: AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021\u00a0update","volume":"81","author":"Friedrich","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"10","key":"10.1016\/j.gofs.2023.12.010_bib0615","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1055\/a-1499-8431","article-title":"AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021\u00a0update","volume":"81","author":"Friedrich","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.gofs.2023.12.010_bib0620","unstructured":"Standard or comprehensive radiation therapy in treating patients with early-stage breast cancer previously treated with chemotherapy and surgery. Disponible sur\u00a0: https:\/\/www.clinicaltrials.gov\/study\/NCT01872975."},{"key":"10.1016\/j.gofs.2023.12.010_bib0625","unstructured":"Comparison of axillary lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy. Disponible sur\u00a0: https:\/\/clinicaltrials.gov\/study\/NCT01901094."},{"key":"10.1016\/j.gofs.2023.12.010_bib0630","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.breast.2022.12.010","article-title":"\u201cThis house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients\u201d","volume":"67","author":"Galimberti","year":"2023","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.gofs.2023.12.010_bib0635","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2023.12.010_bib0640","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1097\/SLA.0000000000004562","article-title":"Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study","volume":"276","author":"Martelli","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.gofs.2023.12.010_bib0645","article-title":"Long-term outcome in patients with nodal-positive breast cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy","author":"Lim","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.gofs.2023.12.010_bib0650","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/cancers15061719","article-title":"Sentinel lymph node biopsy in breast cancer patients undergoing neo-adjuvant chemotherapy: clinical experience with node-negative and node-positive disease prior to systemic therapy","volume":"15","author":"Tinterri","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.gofs.2023.12.010_bib0655","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1245\/s10434-023-13759-y","article-title":"Changes in surgical management of the axilla over 11\u00a0years \u2013 report on more than 1500\u00a0breast cancer patients treated with neoadjuvant chemotherapy on the prospective I-SPY2\u00a0Trial","volume":"30","author":"Boughey","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2023.12.010_bib0660","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","article-title":"Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy","volume":"25","author":"Nguyen","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2023.12.010_bib0665","doi-asserted-by":"crossref","first-page":"1184021","DOI":"10.3389\/fonc.2023.1184021","article-title":"Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)","volume":"13","author":"Garcia-Tejedor","year":"2023","journal-title":"Front Oncol"},{"issue":"25","key":"10.1016\/j.gofs.2023.12.010_bib0675","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N Engl J Med"},{"issue":"34","key":"10.1016\/j.gofs.2023.12.010_bib0340","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2\u2212, node-positive, high-risk, early breast cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718924000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718924000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:43:50Z","timestamp":1762854230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718924000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2468718924000035"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2023.12.010","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peut-on surseoir au curage axillaire en cas de carcinome mammaire invasif avec envahissement ganglionnaire\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}